Emily’s Perspective: Facts and Myths about Epilepsy
Do you know the differences between facts and myths surrounding Epilepsy?… Read More
Local Events: Glow Walk Run for Epilepsy Foundation NJ
What Join the Epilepsy Foundation NJ as they raise awareness and dollars to provide education, recreation, and support to individuals living with epilepsy in New Jersey. Where/When 5K & Family Fun Walk Sunday, October 25, 2015 Liberty State Park Jersey City, NJ Family Fun Walk The 2nd Annual Glow Walk will be … Read More
Epilepsy Blog Relay™: Blog Schedule is Full
You may be aware that we are gearing up for our next Epilepsy Blog Relay™, which will run throughout November 2015 to mark Epilepsy Awareness Month. I am pleased to announce that our blogger participant schedule is full for the November ’15 relay. November Relay Badge If you are a November Blogger, … Read More
Emily’s Perspective: Parenting with Epilepsy
Many people living with Epilepsy are also parents. In this article, I offer suggestions for parenting while managing Epilepsy.… Read More
Leila’s Ideas: Balancing Life and Epilepsy
Trying to live a “normal” life while managing Epilepsy can be difficult. How are you balancing life and epilepsy?… Read More
Epilepsy Blog Relay™: Gearing up for November 2015
November draws closer and that means we are gearing up for Living Well With Epilepsy’s second Epilepsy Blog Relay™. For anyone who may have missed the relay in June, this is an epilepsy awareness movement to designed to maximize collaboration and eliminate stigma. The Epilepsy Blog Relay™ engages people living with epilepsy, … Read More
Living Well With Epilepsy Founder chats LIVE with the Healtheo360 team
I was recently invited to be the guest host on h360 LIVE, which is Healtheo360’s live talk show. The show was fun and I thought you might want to take a look. … Read More
Sunovion’s Aptiom® gets FDA Approval as Monotherapy for Partial-Onset Seizures
Sunovion Pharmaceuticals Inc. (Sunovion) announced on August 28, 2015 that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for Aptiom® (eslicarbazepine acetate) as monotherapy for the treatment of partial-onset seizures.… Read More